Sign inJoin waitlistJoin the waitlist

YN

Yana Najjar

University of Pittsburgh Physicians

Credentials: · · ·

History

Hematology and Medical Oncology
UPMC Medical Education
2014–2017
Internal Medicine
MedStar Health Georgetown University
2011–2014
Doctor of Medicine
2005–2009

Research

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Science · 2021 · 1,389 citations
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Review · Nature reviews. Immunology · 2024 · 265 citations
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma
JCI Insight · 2019 · First of 9 authors · 197 citations

John Kirkwood
23 papers
Diwakar Davar
20 papers
HZ
Hassane Zarour
12 papers
JL
Jason Luke
11 papers
Arivarasan Karunamurthy
8 papers
Ryan Augustin
7 papers · 7 as a resident
Sunandana Chandra
7 papers
Ryan Sullivan
5 papers
Allison Betof
4 papers
AL
Aofei Li
4 papers · 4 as a fellow
EB
Elizabeth Buchbinder
4 papers
Inderjit Mehmi
4 papers

Grants

Dissecting the Role of Hypoxia in T Cell Differentiation in Cancer
National Cancer Institute · R01
PI · $2.4M · University of Pittsburgh at Pittsburgh
2023–2027

Clinical trials

Evaluation of Hypoxia in Primary Melanoma
Principal investigator · Recruiting
Yana Najjar
2025–2029
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
Principal investigator · Recruiting · Early phase 1
Yana Najjar
2024–2029
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Principal investigator · Active not recruiting · Phase 1
Yana Najjar
2021–2027
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
Principal investigator · Recruiting
Yana Najjar
2021–2029